RightFit
RecruitingNot applicable

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
3 Years to 9 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether CareMeds, a parenting skills program to help children take medicine, is practical to use and acceptable to parents. It is for parents of children ages 3–9 being treated for acute lymphoblastic leukemia (ALL), a type of blood cancer. The study plans to include 100 parents at sites in Buffalo, NY, and Atlanta, GA.

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • You are the parent of a child diagnosed with ALL and being treated at a study site.
  • You are the main person responsible for your child's medicine.
  • Your child is 3–9 years old.
  • Your child's treatment includes cancer medicine taken by mouth at home, such as 6-MP.
  • You speak English or Spanish fluently.
  • You understand that this is a research study and sign an approved consent form before any study procedures.

Who can't join

  • You are unwilling or unable to follow the study requirements.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Parent of a child who is diagnosed and being treated for any type of acute lymphoblastic leukemia (ALL) at a study site. * Parent has primary medication responsibility. * Pediatric patient aged 3-9 years * Child on therapy that includes home-based oral anti-cancer medication, such as 6-MP. * Parent has verbal English or Spanish fluency. * Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure Exclusion Criteria: * Parent is unwilling or unable to follow protocol requirements

Study sites (1)

NY